Immunotherapy for Metastatic Renal Cell Carcinoma
Authors
Affiliations
Geng B, Liu W, Wang J, Zhang W, Li Z, Zhang N Front Pharmacol. 2024; 14:1333507.
PMID: 38178861 PMC: 10765515. DOI: 10.3389/fphar.2023.1333507.
DAniello C, Berretta M, Cavaliere C, Rossetti S, Facchini B, Iovane G Front Oncol. 2020; 9:1400.
PMID: 31921657 PMC: 6917607. DOI: 10.3389/fonc.2019.01400.
Engrailed-2 is down-regulated but also ectopically expressed in clear cell renal cell carcinoma.
Lai C, Pan B, Luo Y, Liang W, Chen J, Ye D Mol Biol Rep. 2014; 41(6):3651-7.
PMID: 24532139 DOI: 10.1007/s11033-014-3229-z.
State of the science: an update on renal cell carcinoma.
Jonasch E, Futreal P, Davis I, Bailey S, Kim W, Brugarolas J Mol Cancer Res. 2012; 10(7):859-80.
PMID: 22638109 PMC: 3399969. DOI: 10.1158/1541-7786.MCR-12-0117.
Treatment selection in metastatic renal cell carcinoma: expert consensus.
Escudier B, Szczylik C, Porta C, Gore M Nat Rev Clin Oncol. 2012; 9(6):327-37.
PMID: 22473096 DOI: 10.1038/nrclinonc.2012.59.